期刊
EUROPEAN JOURNAL OF IMMUNOLOGY
卷 50, 期 9, 页码 1321-1334出版社
WILEY
DOI: 10.1002/eji.201948491
关键词
Hydrolase; IFN-gamma; Interferonopathies; IRF1; SAMHD1; STAT1
类别
资金
- MINECO [SAF2014-52887-R, BFU2017-85353]
- APIF grant from the University of Barcelona
SAMHD1 is an enzyme with phosphohydrolase activity. Mutations in SAMHD1 have been linked to the development of Aicardi-Goutieres syndrome in humans. This enzyme also has the capacity to restrict HIV virus replication in macrophages. Here, we report that Samhd1 is highly expressed in murine macrophages and is regulated by proinflammatory (IFN-gamma and LPS) but not by anti-inflammatory (IL-4 or IL-10) activators. The induction of Samhd1 follows the pattern of an intermediate gene that requires protein synthesis. In transient transfection experiments using the Samhd1 promoter, we found that a fragment of 27 bps of this gene, falling between -937 and -910 bps relative to the transcription start site, is required for IFN-gamma-dependent activation. Using EMSAs, we determined that IFN-gamma treatment led to the elimination of a protein complex. Chromatin immunoprecipitation assays and siRNA experiments revealed that IRF1 is required for IFN-gamma- or LPS-induced Samhd1 expression. Therefore, our results indicate that Samhd1 is stimulated by proinflammatory agents IFN-gamma and LPS. Moreover, they reveal that these two agents, via IRF1, eliminate a protein complex that may be related to a repressor, thereby, triggering Samhd1 expression.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据